There are over 300 million people around the globe
who live with chronic inflammatory conditions.
Patients living with unresolved Inflammation can have chronic, debilitating pain - pain that impacts their quality of life and makes day-to-day functioning difficult to manage. Even seemingly simple tasks like going to work, attending to daily tasks and basic movements can become unendurable for patients. A better solution is desperately needed.
These chronic inflammatory conditions have profound impact on health through loss of strength and function, and they can damage multiple organ systems including joints, nerves, skin, eyes and the digestive system. To reflect this extensive unmet need spanning multiple diseases, we are evaluating our lead therapeutic candidate, XT-150, across multiple treatment indications in preclinical and clinical studies.
Peripheral Neuropathic Pain - Lumbar Radiculopathy
Central Neuropathic Pain
Amyotrophic Lateral Sclerosis
Dermal, Ophthalmic, Gastrointestinal